Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages by unknown
SPECIFIC  ANTIMONONUCLEAR  PHAGOCYTE 
MONOCLONAL  ANTIBODIES 
Application to the Purification of Dendritic Cells and the Tissue 
Localization of Macrophages* 
BY WESLEY C.  VAN VOORHIS, RALPH  M.  STEINMAN,*  LAURA  S.  HAIR, 
JEREMY  LUBAN, MARGIT  D.  WITMER, SUMI  KOIDE, ANn 
ZANVIL  A.  COHN 
From The Rockefeller University,  New York 10021 
The monoclonal antibody technique is providing new reagents for the study 
of mononuclear phagocytes. Among other applications, specific antibodies should 
make it possible to distinguish macrophages from other cell types in suspension 
and tissue sections. This potential has not been fully exploited, since the number 
of specific, panmacrophage reagents is limited. In mouse, a  single monoclonal 
antibody, F4/80, appears to be truly macrophage restricted (1, 2). In rat, guinea 
pig, and rabbit,  macrophage-specific reagents have yet to be described to our 
knowledge. In  man,  several antimonocyte antibodies have been produced (3- 
10).  However,  there  has  been  little  work  using these  reagents to  distinguish 
macrophages from dendritic cells and to visualize macrophages in tissue sections. 
The distinction between macrophages and dendritic cells is critical, since the 
two cell types differ so markedly in functional capacities. The dendritic cell lacks 
Fc receptors (2,  1 1,  12), does not exhibit active phagocytic or pinocytic activity 
(1 1), but is the principal accessory cell needed to stimulate lymphocyte responses 
(see 13). Recently it has been shown that enriched populations of dendritic cells 
from human blood  are markedly more potent than  monocytes in  stimulating 
mixed leukocyte reactions and polyclonai T  cell mitogenesis (14,  15). 
Here we describe  monocional antibodies  directed to  an  antigen  that  is  re- 
stricted to  mononuclear phagocytes including monocytes in blood and macro- 
phages in lung, skin, spleen, and lymph node. We then use the monoclonals in 
two types of experiments to further characterize human mononuclear phagocytes 
and dendritic cells. First, depletion of monocytes with antibody and complement 
can be used to prepare circulating dendritic cells in high purity and yield. Second, 
the monoclonals stain macrophages in tissue sections, localizing this cell type to 
the dermis of skin, red pulp of spleen, and lymphatic channels of lymph node. 
In contrast, presumptive dendritic cells are localized in entirely different ana- 
tomic  regions:  skin  epidermis,  splenic  white  pulp,  and  lymph  node  cortex. 
Therefore  these  monoclonal  antibodies  provide  a  clear  distinction  between 
macrophages and dendritic cells in blood and tissues. 
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Materials and Methods 
Cells.  Blood was obtained from normal volunteers, and leukocyte-enriched buffy coats 
were purchased  from  the  Greater New  York  Blood Center.  Mononuclear ceils  were 
harvested from the interface of Ficoll-Hypaque (density =  1.077;  Histopaque  1077-1; 
Sigma Chemical Co., St. Louis, MO) columns and cultured for 1-2 h on 100-mm plastic 
culture  dishes.  The  medium  was  5%  heat-inactivated fetal  calf serum  (FCS) 1 (Sterile 
Systems, Logan, UT, and Kansas City Biologicals, Kansas City, MO)-RPMI 1640 (Grand 
Island Biological Co., Grand Island, NY) supplemented with 20 ttg/ml gentamycin, 100 
U/ml penicillin, 1 mM glutamine, and 5 x  10  -5 M 2-mercaptoethanol. Nonadherent cells 
(~70% of the total) were removed with several washes  and used to prepare T  cells by 
rosetting with neuraminidase-treated sheep erythrocytes or by nylon wool filtration (14). 
Adherent  cells  were  cultured  overnight  and  separated  into  monocyte-,  B  cell-,  and 
dendritic cell-enriched fractions as  described (14).  T  lymphoblasts were prepared by 
stimulating nonadherent cells with 2 ug/ml phytohemagglutinin (Burroughs Wellcome & 
Co.,  Greenville,  NC)  for 4  d  in  5%  FCS-RPMI  1640  medium.  B  lymphoblasts  were 
prepared by stimulating high density B cell-enriched fractions (14) with 3 #g/ml pokeweed 
mitogen (Difco Laboratories Inc., Detroit, MI) for 4 d in 5% FCS-RPMI-1640 medium. 
Granulocytes were kindly provided by Dr. H. B. Fleit (The Rockefeller University) who 
sedimented  the  granulocytes  through  Ficoli-Hypaque, removed most  erythrocytes by 
dextran sedimentation, and depleted residual erythrocytes  by hypotonic lysis (16). Platelets 
were present in mononuclear cell fractions and could be isolated because they did not 
pellet at  180 g  for  10  rain.  To study the  stability of cell surface antigens in culture, 
monocyte-enriched fractions were maintained for I-3 wk either adherent to glass cover- 
slips in  10% AB+ human serum-RPMI  1640, in plastic culture dishes in 5% FCS-RPMI 
1640, or in teflon beakers as described (17; kindly provided by Dr. S. B. Wright). The 
cultured cells were >98% viable monocytes by morphology, nonspecific esterase reactivity, 
and  binding  of specific  monoclonal  antibodies.  Dr.  A.  Fels  and  Dr.  T.  Nash  (The 
Rockefeller University) provided alveolar macrophages by bronchial lavage of nonsmok- 
ers, followed by collection of mononuclear cells on Ficoll-Hypaque columns, and adher- 
ence to glass coverslips (18). Several human cell lines were provided by Dr. J. C. Unkeless 
(The  Rockefeller  University)  and  Dr.  H.  B.  Fleit:  HL60  (promyelocyte-like), K562 
(multipotential  blood  cell  precursor),  U937  (immature  myeloid), and  Daudi  (B  cell). 
Several  human  lymphocyte lines  were  provided  by  Dr.  L.  Mayer  (The  Rockefeller 
University): T  cell lines CEM T and Jurkat, and B cell lines SeHa D, 8866P, and 32al. 
Monodonal  Antibodies.  A  large  panel  of mouse  anti-human  monoclonal antibodies 
(Table I) was produced in our lab and obtained from outside sources. For the new reagents 
(3C10,  1D9,  1E8),  a  BALB/c mouse (The Trudeau Institute, Saranac Lake, NY) was 
injected intraperitoneally with  108  blood monocytes in  saline  three  times at  monthly 
intervals, and four times with 3-5 x  108 monocytes on each of the 4 d before fusion (19). 
For 9.3F10,  which recognizes Ia-like or class II major histocompatibility products (see 
Results),  exactly the  same  protocol was  used  except that  dendritic  cell-enriched (14) 
preparations were injected into mice. Spleen cells from these mice were fused to P3U 1 
myeloma cells at a ratio of one myeloma cell to five spleen cells as described (20). The 
products of these fusions were seeded at 5 X 104 myeloma cells per 0.32-ram  2 microwell 
(3596;  Costar,  Cambridge,  MA)  with  100  /A of hypoxanthine-aminopterine-thymidine 
(HAT) culture medium (Dulbecco's minimal essential medium, supplemented with HAT, 
horse serum, FCS, vitamins, and NCTC 109 medium as described [20]). 
The immunization method of Staehli (19) that we used provided a  large number of 
hybrids reactive with human leukocytes, so that a rapid radioimmunoassay was used to 
detect antibodies of interest. A  large panel of test cells and cell lines (see above) were 
attached tc Terasaki microassay plates (3034;  Falcon Labware, Oxnard, CA) that had 
been exposed to 100 ug/ml poly-L-lysine (70,000 average tool wt; P2636; Sigma Chemical 
Co.) in phosphate-buffered saline (PBS) for 20 min, rinsed in distilled water and dried. 
l Abbreviations used  in this paper:  FCS,  fetal calf serum; HAT, hypoxanthine-aminopterin-thymi- 
dine; PBS, phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide  gel electro- 
phoresis. 128  ANTIBODIES  DELINEATING  HUMAN  MACROPHAGES,  DENDRITIC  CELLS 
TABLE  I 
Monoclonal Mouse Antihuman Leukocyte Antibodies 
Molecular 
Name  Ig sub-  Source  weight of  Specificity  Reference 
class  polypeptide 
T29/33  lgG2b  Dr. I. S. Trowbridge,  200,000  All leukocytes (Leu-  21 
Salk Inst., CA  kocyte-common 
Ag) 
OKlal  IgG2~  Ortho Diagnostic Sys-  34,000,  HLA-class II Ag  22 
terns Inc., West-  29,000 
wood, MA 
Ortho Diagnostic Sys-  170,000 
terns Inc. 
OKMI  lgGeb  Monocytes, natural  3 
killer cells granu- 
locytes, T3' 
Monocytes, granulo-  4 
cytes 
63D3  lgG~  Bethesda Research  200,000 
Laboratories, 
Gaithersburg, MD 
61 D2  IgG2a  Bethesda Research  44,000  4 
Laboratories 
Leu 1  IgG2a  Becton, Dickinson &  67,000  23 
Co., Oxnard, CA 
3G8  IgG1  Dr. H. B. Fleit, The  66,000,  Anti-Fc 3' receptor  16 
Rockefeller Univ.  53,000  on human leuko- 
cytes 
1  B4  IgG2a  Dr. S. D. Wright,  182,000,  Complement recep-  In preparation 
The Rockefeller  123,000,  tor (C3bl) on hu- 
Univ.  105,000  man leukocytes 
BA-I  IgM  Hybritech, Inc., San  NA  B cells, granulocytes  24 
Diego, CA 
OKT6  lgGi  Ortho Diagnostic Sys-  52,000  Thymocytes, Lan-  25 
terns Inc.  gerhans' cells 
1  D9  IgGl  Authors  55,000  Monocytes  This paper 
3C 10  lgG2b  Authors  55,000  Monocytes  This paper 
1E8  IgG~  Authors  ND  Monocytes, granulo-  This paper 
cytes 
9.3F10  IgG~a  Authors  29,000,  HLA-class II Ag  This paper 
33,000 
HLA-class I Ag 
All T cells 
1-4 x  10  4 cells in 5-10 #1 of RPMI  1640 with 0.02%  NaNs (azine) were added to each 
well. The plate was centrifuged at  150 g  for 5  min at 4°C and quenched in cold RPMI 
1640 with 10% horse serum and azide. After 20 rain, the fluid was aspirated and 10 t~l of 
culture supernatant was added for 1 h  on ice. The plates were rinsed by dipping in cold 
PBS with azide, aspirated, and exposed to  10 #1 of 5 #g/ml  125I-F(ab')~ affinity-purified 
rabbit anti-mouse lgG (specific activity of 6 X  l0  s cpm/#g) in RPMI 1640 with 10% horse 
serum and azide on ice for 30 min.  Finally the plates were rinsed, dried, and autoradi- 
ographed for 3-24 h at -70°C using Kodak XAR5 film (Eastman Kodak Co., Rochester, 
NY) and an intensifying screen (Lightening Plus; Dupont Co., Wilmington, DE). 
Using this technique, we noted that hybrid wells 3C 10 and 1  D9 reacted with monocytes 
alone;  1E8  with  monocytes, granulocytes, and  the  U937  and  HL60  cell lines; and the 
commercially available reagent  OKMI  with  granulocytes and  monocytes.  In a  similar 
assay, 3C10,  1 D9, and  1  E8 did not show detectable binding to B cells, T  cells, dendritic 
cells, and three B cell and two T  cell lines, suggesting that the reagents were specific for 
myeloid elements.  In contrast,  9.3F10  reacted with monocytes, B  cells, dendritic cells, 
and three B cell lines, but not with granulocytes, T  cells, two T  cell lines, and the U937, VAN  VOORH1S  ET  AL.  129 
HL60,  and  K562  cell lines,  indicating  it was an  anti-Ia or anti-class II reagent.  Many 
additional hybrids were identified with similar reactivity patterns to 3C 10,  I D9,  1E8, or 
9.3F10.  The latter were cloned in  soft agar, and  further characterized as described in 
Results. All hybridoma clones produced an Ig-rich ascites in DBA/2 X BALB/c F~ mice. 
Purification and  Radiolabeling of Monoclonal Antibodies.  Monoclonal  antibodies  3C10, 
1Dg,  1E8, and 9.3F10 were purified from ascites using 45% (vol/vol) (NH4)2804 precip- 
itation followed by ion exchange chromatography on diethylaminoethyl cellulose (DE-52; 
Whatman  Inc.,  Clifton,  N  J).  The  Ig  fraction  gave a  single  band  on  cellulose  acetate 
electrophoresis that  co-migrated with  the  monoclonal band in  the  unseparated ascites. 
The  subclass of the  purified  antibody  was  determined  by Ouchterlony  analysis  using 
subclass-specific antisera prepared in goats (Meloy Laboratories Inc., Springfield, VA) and 
the results are presented in Table I. To prepare active (see Results) Fab fragments of the 
3C10  antimonocyte and  9.3F10  anti-class II antibodies,  Ig at  8  mg/ml and  5  mg/ml, 
respectively, was digested with  1% (wt/wt) papain (P-4762; Sigma Chemical Co.) in pH 
5.5 0.1  M sodium acetate buffer with 2 mM EDTA and 10 mM 2-mercaptoethanol for 4 
h at 37°C. The reaction was stopped by bringing the solution to 20 mM iodoacetamide. 
The mixtures were dialyzed into 25 mM Tris pH 8.0 and passed over DE-52. Following 
electrophoresis on  11% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) (26) under reducing conditions, the papain digests contained four to five polypep- 
tides, including the candidate Fc, Fd, and light chain portions; the flow-through fractions 
were the presumptive Fab fragments with only two bands (Fig.  1). The intact antibodies 
and digests reacted with subclass-specific antisera, but the flow-through Fab fractions did 
not; all reacted with rabbit anti-mouse IgG (heavy and light chains). 
Antibodies were labeled with Na-~25I (carrier-free; New England Nuclear, Boston, MA) 
using  lodo-Gen  (Pierce  Chemical  Co.,  Rockford,  IL)  as  the  oxidizing  agent  (27)  as 
described  (2).  The  iodinated  and  noniodinated  antibodies  competed  for  binding  to 
monocytes with equal efficiency (see Results). 
Binding of  Monoclonal Antibodies to Cells  In Vitro.  Indirect immunofluorescence was done 
using  a  sensitive  biotin-avidin  system  as  described  (14).  Briefly,  cells  were  exposed 
FIGURE 1.  Analysis  of 3C10 and 9.3F10 Ig and Fab fragments. One-dimensional 11% SDS- 
PAGE was run under reducing conditions and stained with Coomassie brilliant blue. 3C10 is 
antimonocyte and 9.3F10 is an anti-HLA class II. For each antibody, samples were analyzed 
from the purified Ig fraction (ascites passed over diethylaminoethylcellulose), the papain (Pap) 
digests, and the Fab fragments purified from the digests. Std, standard. 130 ANTIBODIES DELINEATING HUMAN  MACROPHAGES,  DENDRITIC CELLS 
successively to:  (a)  mouse anti-human monocional antibody, (b) biotinylated horse anti- 
mouse Ig (Vector Laboratories Inc., Burlingame, CA), and (c) fluorescein-avidin (Vector 
Laboratories Inc.). Biotinylated horse anti-human Ig (Vector Laboratories Inc.) was used 
at 20 #g/ml to stain B cells. 
Quantitative binding studies with monoclonal antibodies were performed at 4°C with 
cells attached to 16-mm poly-L-iysine-coated macrowells (3524; Costar) as described above 
for the  screening  radioimmunoassay,  except  that  the  volume  of the  well  was  always 
maintained at 0.25 ml;  1-4 ×  105 cells were used per well; and the bound radioactivity 
was determined by wiping the cells with cotton swabs and counting these in a  Packard 
gamma counter  (Packard  Instrument Co.,  Downers Grove,  IL). Additional  details are 
provided in the legends to Tables IV-V. 
Quantitative binding studies were used to monitor the effect of protease treatment on 
monocyte-specific and class II antigens. Treatment with proteases was done in suspension 
at 5 ×  106 cells/mi in PBS with 1 mg/mi of either TPCK-trypsin (T8642), chymotrypsin 
(C4129; Sigma Chemical Co.), or pronase (53702; Calbiocbem-Behring Corp., La Jolla, 
CA)  for  15  min  at,37°C;  or  by 0.1  IU/ml  neuraminidase  (vibrio cholerae;  480717; 
Calbiochem-Behring  Corp.)  for  45  min  at  37°C.  Viability was  >90%  by trypan  blue 
exclusion after each treatment. Cells were then centrifuged onto poly-L-iysine-coated 16- 
mm wells at 4 ×  105 cells per well, and the amount of antigen was quantified as above. 
Ident~cation of the Polypeptide Carrying the 3C10/1D9 Monocyte Antigen.  The "western 
blot" procedure was modified slightly from those described by Towbin et al.  (28) and 
×  10  adherent cells were soluhilized in lysis buffer, i.e.,  Johnson et al. (29).  In brief, 5  6 
PBS with 0.5% NP40 detergent, 0.2 trypsin inhibitory units trasylol (aprotinin; A-6012) 
and 2 mM phenylmethylsulfonylfluoride (P-7626; Sigma Chemical Co.). The lysate was 
cleared by centrifugation at 600 g for 10 min, and then 20,000 g for 20 min. The iysate 
was mixed 1:1 with sample buffer (4% SDS,  24% sucrose, 0.05% bromphenol blue,  100 
mM Na2CO3,  pH 8.5), boiled for 2 min, and electrophoresed 10 cm on a  1-mm, 4-11% 
gradient SDS-PAGE. The proteins were transferred from the gel lane onto nitrocellulose 
(BA85;  Schleicher  & Schuell,  Inc.,  Keene,  NH) by electrophoresis.  The nitrocellulose 
filter was incubated for  16  h  with  PBS-Tween (10% horse serum,  0.1%  gelatin,  0.1% 
NaNa, 0.05%  Tween  20 in  PBS),  which served as both wash and carrier buffer for all 
incubations.  The  filter  was  exposed  at  4°C  for  20  h  to  either  directly  125I-labeled 
monoclonal antibody or unlabeled monoclonal antibody (sandwich assay), washed four 
times over 45  rain at room temperature and,  for the sandwich assay, exposed to  125I- 
F(ab')2 rabbit anti-mouse Ig at 4°C for 20 h. The blot was then washed extensively and 
autoradiographed for 16-48 h as above. 
The immunoprecipitation procedure was carried out on overnight-cultured, adherent 
mononuclear cells that were surface labeled with '25I and iactoperoxidase/glucose oxidase 
(30).  The cells were solubilized and cleared by centrifugation as described above. Then 
SDS was added to a final concentration of 0.2%, and the lysate was preabsorbed for 1 h 
at  4°C  with  100  /agm  crude  mouse  immunoglobulin  (45%  (NH4)~SO4  precipitate  of 
nonimmune mouse serum) coupled to Sepharose 4B (Pharmacia Fine Chemicals, Piscata- 
way, NJ), per 106 cell equivalents. The supernatant representing 106 cell equivalents was 
then absorbed with  100 #gm of antibody coupled to Sepharose 4B for 1 h at 4°C. The 
beads were washed three times in lysis buffer with 2% FCS and two times in lysis buffer 
alone. The antigen was released by boiling with sample buffer and 50 mM dithiothreitol 
and electrophoresed for 20 cm. The gel was dried and autoradiographed for 7 d. 
Complement-mediated Cytotoxicity.  Killing  with  antibody  and  rabbit  complement  was 
accomplished by exposing cells (1.7-2.5 x  106 cells/ml) to antibody (3C10 antimonocyte 
at I0 #g/ml; 9.3F10 anti-Ia at 3/zg/ml; Leu-1 anti-T cell at 3 gg/ml; BA-1 anti-B cell at 
3 #g/mi) and rabbit serum (selected for low background cytotoxicity and stored at -70 °C 
after lyophilization; 1:9 final dilution) for 1 h at 37°C. All reagents were diluted in 0.3% 
bovine  serum  albumin,  25  mM  Hepes,  RPMI  1640  pH  7.4,  and  deoxyribonuclease 
(DNAase I; Sigma Chemical Co.) was present at  10 t~g/ml.  The percentage killed was 
determined by the reduction of viable cells (trypan blue exclusion test) as compared with 
the  mean  of the  control  incubations;  i.e.,  no  treatment,  heated  (56°C  for  30  min) VAN  VOORHIS  ET AL.  131 
complement alone, active complement alone, and heated complement plus antibody. The 
standard error of the averaged controls was <10%. The percentage of monocytes was 
monitored by staining cytocentrifuge  preparations with a-naphthyibutyrate for nonspecific 
esterase according to the  method of Li et al.  (31).  Cells  with  diffuse red cytoplasmic 
staining were scored as monocytes. Staining for myeloperoxidase, with diaminobenzidine 
tetrahydrochioride and hydrogen peroxide (32), was also used to count monocytes with 
similar  results.  However the  percentage  of monocytes that  were  peroxidase positive 
diminished to ~ 50% after overnight culture. 
Dendritic Cell Purification with Cytotoxic Cell-specific Antibodies.  To enrich for dendritic 
cells using cell-specific antibodies, we began by treating 0.5-5 ×  108 blood mononuclear 
cells with 3C 10 antimonocyte antibody and complement, or complement alone as outlined 
above. The cells were washed and adhered in  100-mm plastic culture dishes for 1 h at 
37°C in 5% FCS medium. The nonadherent cells were removed with five rinses and the 
adherent monolayers were cultured for  18 h.  Most of the adherent cells  had released 
from the plastic, and these were retreated with 3C10 as well as BA-1 and Leu-1 (anti-B 
and -T cell, respectively) antibodies and complement, or just complement for the control 
cells. Almost all of the viable cells (~80%) were retrieved by flotation in columns of dense 
bovine plasma albumin (P =  1.082) as described (14). This fraction was highly enriched 
for dendritic cells (see Results). An alternative approach to eliminate monocytes was to 
treat mononuclear cells with 3C10 antibody and complement after, rather than before, 
adherence to plastic. The former requires less complement, but the latter approach was 
used in this paper to establish that normal numbers of dendritic cells adhere to plastic 
after elimination of most monocytes. 
Staining Tissue Sections with Monoclonal Antibodies.  Skin biopsies were obtained by Dr. 
W.  R.  Levis (The Rockefeller University) from patients with leprosy, but normal skin 
samples were also stained. Spleen and lymph node were provided by the Tumor Procure- 
ment Center of Memorial Sloan-Kettering Cancer Center, New York. The tissues,  which 
did not contain tumor cells, were frozen in liquid nitrogen, embedded in OCT embedding 
medium (Lab-Tek Div., Miles Laboratories Inc., Naperviile, IL), sectioned at 6-8 #m 
with a cryostat, and stored at -20°C. The sections were fixed before staining for 30 s 
with ice-cold acetone. Immunoperoxidase staining was done as previously described for 
immunofluorescence of tissue sections (33), except that after treatment of tissue sections 
with  monoclonal  antibody  and  biotinylated  horse-anti-mouse  IgG,  the  sections  were 
treated  with  20  #g/ml  avidin-horseradish peroxidase (Vector Laboratories Inc.),  and 
developed with 0.4 mg/ml 3,3' diaminobenzidine tetrahydrochloride (Polysciences Inc., 
Warrington, PA) in 0.05 M Tris buffer, pH 7.6, with 0.01% HeO2 for 10 min at room 
temperature.  Sections were stained for 3  min  with Gill's hemotoxylin (formulation  1; 
Fisher Scientific Co., Fairlawn, N  J). 
Results 
The purpose of this study was to develop monoclonai antibodies that reacted 
only with mononuclear phagocytes in blood and in tissues, and not with dendritic 
cells.  The  monocionais could then be  used  to help purify dendritic  cells from 
blood and to show that macrophages and dendritic cells occupy distinct anatomic 
compartments in spleen, lymph node, and skin. 
Cell Specificity  of 3ClO,  ID9, and 9.3F10 Monoclonal Antibodies.  Initial screening 
with a microradioimmunoassay (see Materials and Methods) indicated that 3C 10 
and  1 D9 reacted with monocytes, whereas 9.3F10 reacted with many cell types 
and lines known to express class II HLA products. After cloning, we evaluated 
culture supernatants, purified Ig, and Fab fragments, for reactivity with a large 
panel of cell types using immunofluorescence and a sensitive biotin-avidin tech- 
nique.  3C 10 and  1 D9 stained monocytes strongly, but did not react with a large 132  ANTIBODIES  DELINEATING  HUMAN  MACROPHAGES,  DENDRITIC  CELLS 
panel of other cell types (Table II). A small percentage of cells were stained in 
the B cell- and dendritic cell-enriched populations,  but this percentage corre- 
sponded  to  the  number  of contaminating  monocytes estimated  by  cytologic 
criteria or by nonspecific esterase staining.  9.3F10  stained most monocytes, B 
cells, and dendritic cells, but not T  cells, platelets, and granulocytes (Table II). 
9.3F 10 stained similarly to OKIa (22), further suggesting that it recognized class 
II HLA antigens. The Fab fragments of 3C 10 and 9.3F 10 stained a similar panel 
of cell types to the corresponding intact Ig (not shown). Leu-1 and anti-Ig reacted 
with most cells in the T  and B cell-enriched populations, respectively, but not 
with monocytes, dendritic cells, and other cell types (Table II). 
By indirect immunofluorescence, the 3C 10 antigen was stable in culture. Thus 
3C10  was expressed on 95% of monocytes that had been cultured for 45 d  in 
teflon beakers to retard adherence (Table II).  Glass-adherent monocytes were 
3C10 + for 21  d, but at 28 d  about 25%  became 3C10-.  The latter frequently 
were multinucleated giant cells.  Alveolar macrophages, obtained by bronchial 
lavage, were all stained with 3C10 and 3C10 Fab fragment, but not with the T 
lymphocyte specific marker, Leu-1 (Table II). 
In the presence of rabbit complement, 3C10  killed >95% of purified mono- 
cytes but did not kill populations enriched in other cell types (not shown). 9.3F 10 
killed 30-70%  of monocytes, as well as most B cells and dendritic cells. 3C10 
efficiently and selectively depleted monocytes from heterogeneous mixtures of 
unfractionated mononuclear cells or plastic-adherent cells (Table III). Total cell 
killing precisely paralleled the loss of cells that stained diffusely for nonspecific 
esterase, an independent monocyte marker (Table III). >95%  of the esterase- 
TABLE  II 
Reactivity of Monoclonal Antibodies with Different Cell Types 
Cells 
Percentage of cells positive after staining with: 
Anti-Hu-  Anti-HLA  Percent 
3C10  9.3F10  OKIa  Leu-1  man Ig  class I  monocytes 
PBMC* 1  30  28  26  60  7  100  31 
PBMC 2  25  23  24  53  14  100  25 
Monocytes  95  78  78  1  2  100  96 
Granulocytes  <1  <1  <1  ND  <1  100  <1 
Dendritic cells  10  100  100  6  44  100  10 
T  Cells (E,+)  1  5  5  95  2  100  1' 
T  lymphoblasts  1  7  7  85  1  100  1 
Non-T (E,-)  4  37  33  8  24  100  4* 
B cells  2  84  81  19  78  100  2 
B lymphoblasts  1  84  82  21  68  100  1 
Erythrocytes  0  0  0  0  0  ND  0 
Platelets  0  0  0  0  0  100  0 
45-d cultured monocytes  100  100  ND  0  ND  ND  100 
Alveolar macrophages  98  99  ND  0  ND  ND  98 
Enriched populations of various cell types were prepared as described in Materials and Methods. 
The dendritic cell-enriched  fraction was 29% dendritic cells, 55% lymphocytes,  and 10% monocytes 
by morphology. The percent monocytes was generally determined by morphology, i.e., circumfer- 
ential spreading, ruffles, large-phase dense lysosomal granules. ND, not done. 
" Peripheral blood mononuclear cells. 
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TABLE  III 
Summary of Cytotoxicity Experiments with Antimonocyte and Anti-Ia Antibodies and Rabbit 
Complement 
Untreated  Antibody- and comple- 
cells  ment-treated cells 
Population  Antibody  n 
Percent ester-  Percent  Percent es- 
ase  ÷  killed  terase  ÷ 
Peripheral blood  3C10  11  31 + 8  27 + 9  2 ±  1 
mononuclear cells  9.3F10  4  31 + 9  20 ± 7  14 ±  13 
Adherent mononuclear  3C10  5  54 + 9  52 _  6  2 -  2 
cells  9.3F10  I  54  65  35 
Unfractionated mononuclear cells or plastic-adherent cells (released after overnight culture) were 
treated with antimonocyte (3C10) or anti-la (9.3F10) antibodies and rabbit complement. We then 
counted the percent (mean +  standard error) of cells that were stained diffusely for nonspecific 
esterase in aliquots of untreated and antibody plus complement-treated cells. The percent killed was 
determined by trypan blue staining. 
TABLE  IV 
Number of 3ClO, 1D9 (Antimonocyte), and 9.3F10 (Anti-la) Binding Sites per Monocyte 
~2sI-labeled antibody 
ng of antibody bound per 4 X 105 monocytes 
(molecules of antibody bound per monocyte) 
Experiment A  Experiment B  Experiment C 
3C10 (intact lg)  3.6 (38,000)  4.9 (47,000)  - 
3C10 (Fab fragment)  1.3 (38,000)  1.5 (46,000)  1.0 (37,000) 
1  D9 (intact Ig)  3.4 (34,000)  -  - 
9.3F10 (intact Ig)  23 (230,000)  -  - 
-  7.5 (225,000)  9.3F 10 (Fab fragment) 
In experiment A, saturating doses of ~2~I-antibody  (3-12 t~g/ml) were added, while in experiment B, 
a constant dose of ~5I-antibody (0.2 •g/ml  for intact and 1.0 ~g/ml for Fab) was mixed with varying 
doses of unlabeled antibody (0-12 t~g/ml for intact, 0-32 tag/ml for Fab). The values given are 
means of at least three saturating doses, the standard deviation being <10%. Nanograms of antibody 
bound was determined by: [(cpm bound -  no-cell control)/specific activity of the antibody]. The no- 
cell control was <2% of the total bound.  1 ng of intact Ig (~ 150 kD) was assumed to be 4.0 ×  109 
molecules and 1 ng Fab (~50 kD)  1.2 ×  10 t° molecules. The monocytes were studied after 1 d of 
culture. 
positive cells were  killed and  the preparations  remained  monocyte  depleted for 
>1  wk in culture.  In contrast, the cytolytic anti-class II reagent  9.3F10  did not 
kill  all  the  monocytes judged  to  be  9.3F10  reactive  by  immunofluorescence 
(Table  III).  We  conclude  that  3C10  and  1D9  recognize  an  antigen  that  is 
mononuclear  phagocyte  specific  and  is  present  on  most  if not  all  fresh  and 
cultured monocytes and alveolar macrophages. 
Quantitative Binding Studies.  Saturable binding of the antimonocyte  and anti- 
class II  monoclonal  antibodies occurred  at  0.3-1.0  #g/ml  for  1-4  x  105  cells. 
Monocytes expressed 3.7-4.7  x  104 binding sites for 3C 10, 3C 10 Fab, and  1 D9, 
and  1.3-2.3  x  105 binding sites for the anti-class II reagent, 9.3F10, and its Fab 
fragment  (see Table  IV).  When  monocytes were cultured  for 6  d,  the  number 
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Quantitative binding studies (not shown) established that the molecule carrying 
the 3C10 antigen was sensitive to trypsin, pronase, and chymotrypsin but not to 
neuraminidase. The 9.3F10  Ia-like determinant was not protease sensitive. 
Binding of 125I-3C10  was blocked by cold  1D9 or cold 3C10  Fab (Table  V). 
However, all the other antibodies in our panel (Table 1), which included several 
antibodies to HLA-class I and II antigens did not inhibit 3C 10 binding (see Table 
V).  We conclude that 3C10 and  1D9 bind to a  similar, non-HLA determinant, 
and that binding is not Fc mediated. 
Identification  of Polypeptides Bearing the 3C10,  ID9, and 9.3FI0 Antigens.  3C10 
precipitated a  major 55 kD polypeptide from monocytes that had been surface 
radiolabeled with Na-12~I and lactoperoxidase-glucose oxidase (Fig. 2, left). The 
same polypeptide was identified with 3C 10 Fab. As anticipated, 9.3F 10 reacted 
with a  33-29  kD  doublet typical of the alpha and beta chains of HLA-class II 
products (Fig. 2). 
By Western blotting, 3C10  (Fig. 2, right) and  1D9 (not shown) again reacted 
with a 55 kD polypeptide. In some blots, a minor 53 kD band reacted with 3C10. 
This  might  have  represented  an  intracellular  precursor  for  the  55  kD  3C10 
surface polypeptide (Fig. 2, right). 
Use of Antimonocyte  Antibodies  in  the  Purification  of Dendritic  Cells.  Although 
blood dendritic cells adhere to plastic, they are far outnumbered by monocytes 
(~20-fold)  and  lymphocytes. We  first noted that  3C10  (antimonocyte),  BA-1 
(anti-B  cell),  and  Leu-1  (anti-T  cell)  efficiently killed populations enriched  in 
monocytes, B cells, and T  cells, respectively, but not dendritic cells (not shown). 
We therefore devised a  procedure (see Materials and Methods) in which mono- 
cyte-depleted adherent cells were prepared,  cultured overnight, and reexposed 
to complement and a  battery of monoclonals: 3CI0,  BA-1, and Leu-1. 80%  of 
the cells that survived cytolysis could be floated free from the dead cells on dense 
albumin columns. The recovery was 0.1-0.2% of the total starting mononuclear 
cells. By cytology (Fig. 3, a-c),  ~70%  of the final low density population were 
TABLE  V 
Competition  for Ie~I-3C10 Binding by Unlabeled Antibodies 
Unlabeled antibody 
Percent binding 
Mean cpm  compared  to no 
minus back-  unlabeled  anti- 
ground  body 
No unlabeled antibody  11,258  - 
9.3F 10 (anti-la)  10.715  95 
1  E8 (antigranulocyte  monocyte)  10,737  95 
T29/33 (antileukocyte)  11,312  100 
1  B4 (anti-Csb~  receptor)  15,510  138 
1  D9 (antimonocyte)  956  8 
3C 10 (antimonocyte)  135  1 
3G8 Fab (anti-Fc 3" receptor)  10,751  95 
3C 10 Fab (antimonocyte)  1,085  10 
L~Sl-3C10 (1 #g/ml) was added to 4 x  105 monocytes  that previously  had 
been exposed for 60 rain to either no other antibody, or to saturating 
levels (50 vg/ml for all except T29/33,  which was  1:100 dilution of 
ascites) of several noniodinated monoclonal  antibodies. VAN  VOORHIS ET  AL.  135 
FIGURE 2.  Immunoprecipitation (left)  and immunoblotting (right)  analysis of the polypeptides 
carrying the 3C 10 and 9.3F  10 antigens. In the immunoprecipitation experiment, a radioiodi- 
nated monocyte lysate was precleared on Sepharose coupled to mouse Ig and then divided 
into aliquots for precipitation with Sepharose coupled to 3C 10 (antimonocyte), I E8 (antimon- 
ocyte, granulocyte), 9.3F10 (anti-class II), or mouse lg. The blotting experiment used directly 
labeled 1~5I-3C10 Ig at 0.08 ttg/ml, 7 × 108 cpm/~g; or an indirect approach (3C10 at 1 #g/ 
ml followed  by J25I-F(ab )~ rabbit anti-mouse Ig at 0.05 ttg/ml, 6 x 10° cpm/#g). 
dendritic cells, and total yield was comparable to controls that had been exposed 
to complement  only (Table VI).  The  dendritic  cell fraction  contained  <1-4% 
monocytes,  identified  by cytology or  nonspecific esterase  staining.  Likewise B 
and T  cells were depleted to <2%,  as monitored by immunofluorescence with 
anti-Ig and  Leu-2a and -3a antibodies.  Controls exposed to complement in the 
absence of antibodies were  ,-,70%  monocytes (Table VI,  Fig.  3d).  Therefore, 
dendritic cells in blood (---,0.5%  of total mononuclear cells) can be purified by a 
technique  that  uses  their  adherence  property  and  the  fact that  they  lack  the 
differentiation markers of other cell types. 
Distribution  of Macrophages  in  Tissue  Sections.  Since  3C10  reacted  with  all 
monocytes and alveolar macrophages,  but not with dendritic cells, this antibody 
was used to outline the distribution of macrophages in frozen sections of spleen, 
lymph node, and skin. In spleen, both 3C 10 and 3C 10 Fab stained large numbers 
of macrophages in the red pulp (Fig. 4). Lymphocytes in white pulp, fibroblasts 
in connective tissue trabeculae, and endothelial and smooth muscle cells of blood 
vessel  walls  were  not  stained.  White  pulp  nodules,  which  probably contained 
most of the dendritic cells (34, 35), had few 3C10  + cells in either T  (Figs. 4, 5) 
or B (not shown) regions. Some 3C 10  ÷ cells, presumably macrophages, abutted 
the central white pulp arteries (Fig. 5). Leu- 1 stained collections oft  lymphocytes 
close to the central arteries (Figs. 4, 5) as well as scattered cells in both red pulp 
(Fig.  4) and  B  cell  follicles (not shown).  The anti-Ia  antibody,  9.3F10,  stained 
both  red  and  white  pulp  intensely.  Ia  ÷  cells  in  T-dependent  areas  probably 
corresponded  to dendritic  or interdigitating  cells (see Discussion) and  far out- 
numbered 3C 10  + macrophages (Fig. 5). 
In node (Fig. 6), 3C 10  ÷ cells were abundant along all of the lymphatic channels. 
This included  the subcapsular sinus into which afferent lymphatics empty; the 136  ANTIBODIES  DELINEATING  HUMAN  MACROPHAGES,  DENDRITIC  CELLS 
FIGURE  3.  Phase-contrast microscopy of low density adherent cells from blood. (a-c) Purified 
dendritic  cell fraction,  prepared  by  cytolytic elimination of monocytes and  lymphocytes as 
described in Materials and Methods. Most of the cells exhibit the typical dendritic appearance 
described previously (14).  (d)  Control low density population  exposed to complement only; 
most of the ceils have the characteristic features of monocytes, while ~  10% are dendritic ceils 
(arrow). (a) x  750, (b) x  1100, (c) ×  750, (d) x  700. VAN  VOORHIS  ET  AL.  137 
TABLE  VI 
Preparation of Human Dendritic Cells by Eliminating Other Cell Types with Monoclonal 
Antibodies and Complement 
Treatment 
Starting num-  Number oflow- 
ber of mono-  density adher- 
nuclear cells  ent cells 
Differential count of low-density 
fractions 
DC  Monocytes  Lymphs 
Experiment 1 
Complement only  5 ×  107 
Complement +  3C10  2 x  108 
Experiment 2 
Complement only 
Complement +  antibodies 
(3C10 +  BA-I +  Leu-1) 
Experiment 3 
Complement only  1 ×  10  a 
Complement +  antibodies  5 ×  10  s 
(3C10 +  BA-1 +  Leu-1) 
% 
1.4 X  106  8  80  12 
5 X 105  43  I  57 
1.5 X 10  a  7 X 106  7  62  31 
3.5 X 108  6 X 105  76  1  23 
4.6 x  106  12  71  17 
5 x  105  80  1  20 
Mononuclear  cells  were  obtained  from  FicolI-Hypaque  columns  and  processed,  as  described  in 
Materials and Methods, to deplete the adherent fraction of monocytes. Then the adherent cells that 
came off the plastic surface after overnight culture were treated again with complement with or 
without monoclonal antibodies as indicated. The cells resistant to cytolysis were recovered on albumin 
columns (low-density adherent cells) and analyzed by phase-contrast microscopy. Round cells were 
classified as ~lymphocytes" since they did not look like dendritic cells (DC) or monocytes; however 
the BA-1- and Leu-l-treated populations lacked typical B and T  cells by surface markers (see Results). 
intermediate sinuses that penetrate the cortex along connective tissue trabeculae; 
and the medullary cords that contain the efferent lymphatics. BC10  reactivity 
was also noted in the center of secondary follicles (germinal centers; not shown). 
However, 3C10 + cells were scarce in thymus-dependent regions (identified by 
abundant Leu-l-positive T  cells, and the presence of postcapillary venules) and 
in follicular collections of small B cells (Fig. 6). 
In normal skin (not shown), a few 3C10 + cells were scattered in the dermis. In 
epidermis, Langerhans' cells were stained with OKT 6  (25),  T29/33  (antileu- 
kocyte) (21),  and  9.3F10  (anti-Ia) reagents,  but  not with  3C10.  Skin  biopsies 
were also studied from patients with lepromatous leprosy (Fig.  7),  since these 
contain macrophage-rich dermal infiltrates and in many cases, abundant epider- 
mal Langerhans' cells (33). The infiltrates contained many 3C 10 ÷ cells, but again 
epidermal Langerbans' cells failed to stain with 3C 10 (Fig. 7). 
We conclude that  3C10  identifies mononuclear phagocytes that are resident 
in dermis, lymph node, and spleen, and that migrate into inflammatory foci. Few 
macrophages are noted in those regions considered to be rich in dendritic cells; 
that is, the two cell types are segregated anatomically. 
Discussion 
We have described an antigen that is widely distributed on human mononuclear 
phagocytes. The antigen is detected by the monoclonal antibodies,  3C10  and 
1D9, and is present on most if not all blood monocytes, alveolar macrophages, 
and macrophages in sections of skin,  lymph node, and spleen.  5C10 and  1D9 138ANTIBODIES  DELINEATING  HUMAN MACROPHAGES, DENDRITIC  CELLS 
FIGURE 4.  Immunocytochemistry of the junction (dotted  line) of red and  white pulp in 
spleen. Adjacent sections were stained with no primary antibody (a); 3C10 antimacrophage 
(b); and Leu-1 anti-T cell (c). The red pulp contains some opaque profiles (a) which represent 
background staining occurring in the absence of primary antibody. The red pulp has many 
3C10  ÷ macrophages (b, arrows) and scattered T cells (c). The white pulp nodule, with central 
arteries (arrowheads), contains an area rich in Leu-I ÷ cells (T area) that lacks 3C10  ÷ cells. 
x 200. 
probably recognize a  related if not identical antigen.  Specifically, the  reagents 
compete for binding to monocytes and immunoprecipitate a similar 55 kD surface 
molecule.  In  both  binding and  immunoprecipitation assays,  3C10  Fab behaves 
identically to intact Ig (Tables IV, V, Fig.  2). This is important since monocytes 
exhibit Fc receptors, which have a  molecular weight of "~55,000 (16,  20).  The 
3C10-1D9 antigen is clearly distinct  from HLA-class II or Ia-like determinants 
which  in  this  paper  were  identified  primarily  with  a  new  monoclonal,  9.3F10 
(Tables  II-IV,  Fig.  2).  Of the  many antimonocyte antibodies  that  have  been 
produced, 3C 10 and 1  D9 most closely resemble the anti-Mo2 reagents described 
by Todd et al. (7,  10). 
Use of Antimonocyte Antibodies  in  the Purification  of Dendritic  Cells.  The  3C10 
and  ID9  antibodies  do  not  stain  (Table  II)  or  kill  dendritic  cells enriched  as 
described previously (14).  In fact elimination of monocytes with 3C 10 antibody 
and  rabbit  complement  can  be  used  to  enrich  dendritic  cells  in  considerable VAN  VOORH1S  ET  AL.  139 
FIGURE 5.  Immunocytochemistry of the periarterial region of splenic white pulp. Adjacent 
sections were stained with 9.3F 10 anti-Ia (left),  3C I 0 antimacrophage (middle),  and Leu-1 anti- 
T  cell (right).  The sections illustrate that the T  area has few macrophages but many la  ÷ cells. 
The latter probably include interdigitating or dendritic cells (see Discussion). x  200. 
purity and yield (Table VI, Fig. 3). The enriched fractions that can be depleted 
of B and T  cells,  with  BA-1  and  Leu-1  antibodies,  contain 65-80%  dendritic 
cells. The identity of the remaining 20-35% is unclear but could include dendritic 
cells that do not spread well at the time of assay. In the accompanying paper 
(36), we also show that heterogeneous cell mixtures can be separated into 1D9 ÷ 
and 1  D9- fractions; the former are highly enriched in monocytes and the latter 
contain the dendritic cells. 
The availability of the  3C10-1D9  antibodies is particularly timely, since the 
separation of dendritic cells from mononuclear phagocytes in man (14) is more 
demanding than in mouse (12). In both species, dendritic cells adhere to plastic 
and account for <1%  of total nucleated cells. However, human blood contains 
large numbers of adherent monocytes (55-30%); mouse lymphoid tissues release 
<5-2% adherent macrophages. Both monocytes and dendritic cells in man have 
a  low buoyant density;  in  mouse,  most  (,--2/3)  dendritic cells  float on  dense 
albumin columns, whereas most macrophages typically pellet. These experimen- 
tal difficulties can be overcome by using 3C10 and  1  D9 to identify and separate 
the  two  cell  types  (Tables  II,  VI,  Fig.  3).  The  experiments  described  here 
represent the first time that antimacrophage antibodies have been used in the 
purification of dendritic cells. 
Distribution  of Macrophages and Dendritic Celts in  Tissues.  Both  3C10  and its 
Fab fragment are effective for immunocytochemical staining of tissue sections. 
Endothelial cells, fibroblasts, lymphocytes, and dendritic cells do not stain with 
3C10, but many 3C10 ÷ cells are found in regions that are known to be rich in 
macrophages: the red pulp of spleen; the areas surrounding lymphatic vessels in 
lymph node capsule, cortex, and medulla; and the dermal inflammatory infiltrates 
of leprosy (Figs.  4-7).  Since we have not used two macrophage labels simulta- 140 ANTIBODIES  DELINEATING  HUMAN  MACROPHAGES,  DENDRITIC  CELLS 
FIGURE 6.  lmmunocytochemistry of lymph node cortex. Adjacent sections were stained with 
Leu-1, anti-Z cell (left) and 3C10, antimacrophage (right).  Lymph node cortex contains two 
kinds of lymphatic tissue: one is  rich in  Leu-1 ÷ T  cells (T) and contains many postcapillary 
venules (I0;  the  other  contains  follicles of Leu-1-  B  cells  (F).  Penetrating the  cortex  are 
connective  tissue  trabeculae  (X)  that  course  from  subcapsular  cortex  to  the  hilum.  The 
trabeculae are  lined with lymphatic channels (not evident in  frozen sections) and sheets of 
3C10  + macrophages (region with dotted line), x  160. 
neously,  we  cannot  be  certain  that  all  tissue  macrophages  stain  with  3C10. 
However, the staining is prominent, and the number of reactive cells is abundant. 
It seems likely that 3C10 acts as a panmacrophage reagent in the tissues we have 
studied. 
Strikingly, 3C 10  + cells are not found in several compartments that are thought 
to be rich  in  dendritic  cells:  white  pulp  of spleen,  cortical  lymphatic  tissue of 
node, and epidermis (Figs. 4-7). Staining with 3C 10 therefore reveals that most 
macrophages and dendritic cells are segregated from one another, a  distinction 
that has never been so dramatically evident. In mouse spleen, dendritic cells can 
be isolated from white but not red pulp (34), and can be visualized by electron 
microscopy  in  white  pulp  (35).  The  white  pulp  dendritic  cells  resemble  the 
"interdigitating  cells" (37,  38) first described by Veldman.  Interdigitating  cells 
are concentrated  in thymus-dependent regions of lymphoid organs in all mam- 
mals.  Several  studies  have  likened  interdigitating  cells  in  tissue  sections  to 
dendritic cells isolated in vitro (39, reviewed in 40).  In epidermis,  Langerhans' 
cells are stellate,  bone marrow-derived,  and  Ia  + (reviewed in 41).  Human  Lan- 
gerhans'  cells,  identified  in  this  study  by  their  reactivity  with  anti-Ia,  anti- 
leukocyte, and OKT 6 antibodies, are 3C 10-; likewise mouse epidermal Langer- VAN  VOORHIS  ET  AL.  141 
FIGURE 7.  lmmunocytochemistry of a skin biopsy from a patient with lepromatous leprosy. 
Adjacent sections were stained with OKT6, anti-Langerhans' cell (left) and 3C10, antimacro- 
phage (right).  A  network of Langerhans'  cell processes is evident in the epidermis, but  this 
network lacks the 3C 10 determinant.  In contrast, the dermal infiltrates of leprosy represent a 
dense network of 3C 10 + O KT6- macrophages, and (not shown) OKT 8*4- lymphocytes (33). 
Although Langerhans'  cells can increase in number  in  leprosy epidermis (33),  their surface 
markers (OKT6  +, 3C10-, Ia  ÷) are comparable to normal skin.  x  160. 
hans' ceils do not react with the F4/80, mac-l, and 2.4G2 monoclonals (Witmer 
and Steinman, unpublished results), each of which binds to macrophages but not 
to dendritic cells (2). Therefore Langerhans' cells, which frequently are likened 
to macrophages, may be part of the dendritic cell system. 
The segregation of macrophages and dendritic cells in spleen and lymph node 
seems appropriate for the two main functions performed by lymphoid organs-- 
clearance of antigen, and development of immune responses. The macrophage 
is the "versatile element of inflammation" (42).  It is endowed with endocytic and 
microbicidal capacities, and these functions are enhanced by the Ig and lympho- 
kine products of stimulated iymphocytes. Macrophages are concentrated in those 
regions where antigen first leaves vascular and lymphatic channels, namely the 
red pulp of spleen and the lymphatic sinuses of node. Therefore, macrophages 
are positioned to scavenge and clear antigen, and likely constitute a major first 
line of host  defense.  In  contrast,  dendritic cells are  "nature's  adjuvant,"  the 
principal accessory cell  required  for  the  stimulation of many lymphocyte re- 
sponses (13). Dendritic cells likely are poised near recirculating lymphocytes, and 
are accessible to antigen that escapes macrophage clearance. Although additional 
immunocytochemical studies of antigen-stimulated tissues are  needed, during 
immune responses lymphoblasts first develop in  regions that are  macrophage 142  ANTIBODIES  DELINEATING  HUMAN  MACROPHAGES,  DENDRITIC  CELLS 
poor  and  dendritic  cell  rich  (see  43-46).  These  anatomical  findings are  an 
important adjunct to  in  vitro  studies that  compare  the  accessory function of 
human  macrophages  and  dendritic  cells.  The  latter  are  the  subject  of the 
accompanying paper (36). 
Summary 
3C 10 and 1  D9 are two related monoclonal antibodies that specifically identify 
human  mononuclear phagocytes in  a  large  number  of sites,  including blood 
monocytes, alveolar macrophages, and macrophages in tissue sections of spleen, 
lymph node, and skin. The antigen persists on monocytes cultured for >4 wk, 
but it is not found on giant cells.  The 3C10-1D9 determinant is carried by a 55 
kD polypeptide, is expressed at ~40,000 copies per monocyte, and is protease 
sensitive. The antigen is clearly different from HLA-class II or Ia-like antigens 
that have been studied with a  new monoclonal 9.3F10.  The 9.3F10 antigen is 
found on B cells,  dendritic cells and monocytes; is protease resistant, and occurs 
on a 33-29 kD doublet typical of class II products. 
The 3C10 monoclonal provides a clear distinction between human mononu- 
clear phagocytes and dendritic cells.  First, monocytes and lymphocytes can be 
eliminated from plastic-adherent mononuclear cells using 3C10,  complement, 
and two previously described cytotoxic antibodies, BA-1  (anti-B cell) and Leu-1 
(anti-T cell).  As a  result,  the  trace dendritic cell  component of blood can  be 
enriched to considerable purity (65-75%) and yield. Second, immunocytochem- 
ical staining of tissue sections reveals that 3C 10  + macrophages are anatomically 
segregated from dendritic cells.  Large numbers of 3C10 + cells are found in red 
pulp of spleen and in regions surrounding lymphatic channels of lymph node. 
However,  3CI0  +  macrophages  are  scarce  in  white  pulp  of spleen  and  the 
lymphocyte-rich cortex  of node  that  are  the  sites  where  dendritic  cells  are 
localized.  3C10 + cells in  skin are  found in  the dermis, particularly in  leprosy 
infiltrates, but  the  Langerhans' cells of epidermis are  3C10-.  The distinctive 
localization of macrophages and dendritic cells is consistent with their respective 
functions as effector and accessory cells in the immune response. 
Received for publication  16 March  1983. 
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